STOCK TITAN
  1. Home
  2. Sec-filings
  3. NMRA
  4. [144] Neumora Therapeutics, Inc. SEC Filing

Neumora Therapeutics (NASDAQ: NMRA) officer plans 41,608-share sale after August trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Neumora Therapeutics, Inc. (NMRA) reported that officer Aurora Daljit Singh filed a notice of proposed sale of 41,608 shares of common stock of Neumora Therapeutics, Inc. The shares are tied to the exercise of employee stock options and are expected to be disposed of on 08/21/2026 through a broker assisted cashless sale on NASDAQ via Merrill Lynch.

The filing also lists prior sales of Neumora common stock by Aurora Daljit Singh during the past three months on four dates in August 2026, each with specified share counts and total sale prices.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 41,608 shares of Common Stock Proposed sale on 08/21/2026 via broker assisted cashless sale
Shares sold on 08/17/2026 146,706 shares Common Stock sold for total proceeds of $220,135.18
Proceeds on 08/17/2026 $220,135.18 Total consideration for 146,706 shares of Common Stock
Shares sold on 08/18/2026 69,149 shares Common Stock sold for total proceeds of $109,621.88
Proceeds on 08/18/2026 $109,621.88 Total consideration for 69,149 shares of Common Stock
Shares sold on 08/19/2026 61,918 shares Common Stock sold for total proceeds of $101,917.37
Shares sold on 08/20/2026 134,452 shares Common Stock sold for total proceeds of $203,583.59
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
broker assisted cashless sale financial
"Broker assisted cashless sale"
Common Stock financial
"Common Stock | 08/21/2026 | Exercise of employee stock options"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise of employee stock options financial
"08/21/2026 | Exercise of employee stock options"

FAQ

What stock sale is being reported for Neumora Therapeutics, Inc. (NMRA)?
The notice reports a proposed sale of 41,608 shares of Neumora Therapeutics, Inc. common stock by officer Aurora Daljit Singh, expected on 08/21/2026 in connection with the exercise of employee stock options via a broker assisted cashless sale.

How will the Neumora (NMRA) shares be sold according to this Form 144?
The 41,608 shares of Neumora common stock are expected to be sold on 08/21/2026 through a broker assisted cashless sale on NASDAQ, with Merrill Lynch identified in the filing as the broker handling the transaction.

Who is selling Neumora Therapeutics (NMRA) shares in this filing?
The selling person is Aurora Daljit Singh, identified as an officer of Neumora Therapeutics, Inc. The filing covers Neumora common stock held for this person’s account, including option-related shares and recent sales reported under Rule 144.

What prior Neumora (NMRA) stock sales are disclosed over the past three months?
The filing lists four prior Neumora common stock sales by Aurora Daljit Singh: 146,706 shares on 08/17/2026 for $220,135.18; 69,149 shares on 08/18/2026 for $109,621.88; 61,918 shares on 08/19/2026 for $101,917.37; and 134,452 shares on 08/20/2026 for $203,583.59.

On which market are the Neumora (NMRA) shares in this Form 144 planned to trade?
The shares covered by the notice are Neumora Therapeutics, Inc. common stock expected to be sold on NASDAQ, with Merrill Lynch identified as the broker for the broker assisted cashless sale scheduled for 08/21/2026.

What type of security is covered in this Neumora (NMRA) Form 144?
The security covered is Common Stock of Neumora Therapeutics, Inc., including shares related to the exercise of employee stock options, with a proposed sale of 41,608 shares and separate disclosure of multiple recent common stock sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR